ATRA+Arsenic
APL2012
Approved small_molecule active
Quick answer
ATRA+Arsenic for Acute Promyelocytic Leukemia is a Approved program (small_molecule) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
- Indication
- Acute Promyelocytic Leukemia
- Phase
- Approved
- Modality
- small_molecule
- Status
- active